KEY ACHIEVEMENTS• Pursued continual career growth across a five-year period, progressing to a Principal Scientist position• Assured the prioritization, overall quality, and timely execution of nonclinical safety deliverables on multiple drug discovery and development projects• Consulted with multi-disciplinary drug discovery teams to characterize and nominate the best molecules for development, as well as clinical development teams to support clinical programs• Trained with study toxicologist on partnering with CROs and development and review of in vivo nonGLP and GLP study protocols and reports RESPONSIBILITIES• Provide effective toxicology leadership for discovery, development, and clinical projects• Engage with senior nonclinical safety (NCS) stakeholders to devise comprehensive strategies pertaining to new pharmaceutical products encompassing resource, budget, and time requirements• Serve as a technical point of consultation for the wider NCS global community, as well as the key interface between therapeutic areas and NCS management• Create target risk assessments and develop fit-for-purpose plans to screen for and manage potential risks for novel therapeutics• Collect and interpret preclinical data and synthesize into an evolving integrated risk assessment • Prepare and submit global regulatory nonclinical documents across end-to-end project phases• Perform comprehensive due diligence activities on potential licensing and acquisition opportunities• Keep informed of latest scientific and technical literature in toxicology pertaining to a diverse range of modalities and therapeutic areas

KEY ACHIEVEMENTS• Rapidly advanced from Postdoctoral Fellow to Scientist in recognition of success in the leadership of a three-year, $500K project at the Armed Forces Radiobiology Research Institute• Performed end-to-end project activities including experimental planning, design and completion, data analysis, budget management, and resource allocation• Demonstrated proof-of-concept that prophylactic administration of a novel drug compound significantly decreased radiation toxicity in several mouse models of hematopoietic acute radiation syndrome• Presented experimental design, results, and insights at multiple scientific meetings• Wrote detailed animal care and use protocols including ad hoc amendments and annual reviews

Edited scientific and medical manuscripts and abstracts for publication.

KEY ACHIEVEMENTS• Partnered with Japanese pharmaceutical employees to enhance oral and written communication skills and presentations in English involving drug development, including clinical, preclinical, QA/QC, safety, and pharmacovigilance• Enabled employees to communicate areas of expertise to individuals of varying cultures and backgrounds

KEY ACHIEVEMENTS• Orchestrated the successful installation of a cell culture facility, while meeting demanding resource, budgetary, and time restrictions• Remained highly adaptable and flexible across challenging biochemical-/immunology-based research projects• Leveraged latest proprietary technology to maximize contributions to company research and objectives• Engaged in comprehensive client site visits to perform the seamless repairing and upgrading of crucial technology• Elevated wider team understanding of cell culture techniques and best practices through the distribution of well-structured training materials and video content

KEY ACHIEVEMENTS• Directed laboratory research operations; designing a novel laboratory technique to adapt polyacrylamide hydrogels to characterize the effects of mechanical tension and TCDD (dioxin) toxicity on hepatic stellate cells• Co-authored a scientific publication, delivered oral presentations, and attended conferences with mentees to present posters to validate hepatic stellate cells as targets for TCDD toxicity• Nurtured the professional growth and technical skill development of multiple students by delivering in-depth training and providing attentive mentorship on individual research projects• Promoted a culture of health & safety best practice by establishing protocols and SOPs on laboratory techniques

KEY ACHIEVEMENTS• Recipient of the 2009 Edgar Gentilli Award from the Royal College of Obstetricians and Gynaecologists, London, England for research on a new treatment option for cervical cancer• Spearheaded the successful design, development, planning, and execution of impactful experiments by leveraging a range of molecular and cellular techniques, while subsequently performing varied statistical analyses on data/results• Successfully identified a mechanism of action for a potential therapeutic in human papillomavirus (HPV)-infected cervical cancer cell lines by disrupting oncogenic signalling pathways• Defined drug-induced effects on cellular proliferation, cell cycle kinetics, apoptosis induction, RNA, and protein targets• Kept updated on emerging research findings and technological developments to elevate personal impact